INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$2.0M

$1,999,147

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Fox Christine • Officer • EVP, U.S. Commercial Sell to Cover 2026-03-05 $250,940 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Fox Christine Officer • EVP, U.S. Commercial Sell to Cover	2026-03-05	$250,940	S	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Fox Christine • Officer • EVP, U.S. Commercial Sell to CoverΔOwn -10.8% 2026-03-04 $295,362 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Fox Christine Officer • EVP, U.S. Commercial Sell to CoverΔOwn -10.8%	2026-03-04	$295,362	S	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Fox Christine • Officer • EVP, Head of U.S. Commercial Sell to CoverΔOwn -30.7% 2025-11-20 $699,523 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Fox Christine Officer • EVP, Head of U.S. Commercial Sell to CoverΔOwn -30.7%	2025-11-20	$699,523	S	Form 4
TEVA S TEVA PHARMACEUTICAL INDUSTRIES LTD Fox Christine • Officer • EVP, Head of U.S. Commercial Discretionary SellΔOwn -51.4% 2025-11-14 $753,321 View Form 4 →
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	Fox Christine Officer • EVP, Head of U.S. Commercial Discretionary SellΔOwn -51.4%	2025-11-14	$753,321	S	Form 4